Brief: Orasure Submits Ct/Ng Molecular Self-Test And Colli-Pee™ Urine Collection Device For FDA Review
05/01/2026 15:20
Jan 5 (Reuters) - OraSure Technologies Inc OSUR.O: ORASURE SUBMITS CT/NG MOLECULAR SELF-TEST AND COLLI-PEE™ URINE COLLECTION DEVICE FOR FDA REVIEW Source text: ID:nGNX7ggFTs Further company coverage: OSUR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OraSure Technologies
See all newsOraSure Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
OraSure Q2 revenue rises on higher diagnostics sales
Brief: OraSure Technologies Q2 Revenue USD 30.6 Million
OraSure Technologies Inc expected to post a loss of 27 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Wabtec, Chubb, CME Group